Business ❯ Investor Relations

Financial Performance

Revenue Growth Earnings Call Earnings Reports Guidance Revenue Forecasts Revenue Generation Liquidity Management Revenue and Losses Key Performance Indicators Operational Efficiency Non-GAAP Measures Adjusted EBITDA

Neuraxis, Nyxoah Post Q1 Gains as Reimbursement Clarity Boosts Early U.S. Sales

Reimbursement wins signal faster paths to breakeven.

Hallador Locks In 12-Year Power Capacity Deal Topping $1 Billion

Pfizer Beats Q1 Forecasts as Newer Drugs Offset COVID Slide

RPM International Shares Jump on Record Q3 and Margin Gains

nCino Reports 17% ACV Growth, Accelerates Shift to AI-Aligned Platform

Guardian Pharmacy Lifts 2026 EBITDA Outlook After Strong 2025, Warns of 2027 IRA Hit

Collegium Reports Record 2025 Results, Projects Strong 2026 for Jornay as Hikma Generic Nears

PBF Energy Sets Early-March Martinez Restart as Heavy Crude Margins Lift Q4

Zoom Raises Full-Year Guidance After Earnings Beat as AI Strategy Gains Enterprise Traction

Symbotic Beats Q4 Revenue Estimates, Guides Above Consensus